The preview version of the exclusive market overview and outlook through 2016 presentation created by IMS exclusively for CPhI South East Asia 2013.

1. The Next Frontier: Indonesia
Opportunities and Challenges in the Indonesian
Pharmaceutical Market - Outlook through 2016
Exclusive to CPhI South East Asia 2013

2. The Next Frontier: Indonesia
• Author: IMS Health
• Contact us:
Rupesh Chudasama
Global Market Measurement, Asia-Pacific and China
Mobile: +61 (0) 420 903 286
Email: rchudasama@au.imshealth.com
Disclaimer
•
The analyses, their interpretation, and related information contained herein are made and provided subject to the
assumptions, methodologies, caveats, and variables described in this report and are based on third party sources and
data reasonably believed to be reliable. No warranty is made as to the completeness or accuracy of such third party
sources or data.
•
As with any attempt to estimate future events, the forecasts, projections, conclusions, and other information included
herein are subject to certain risks and uncertainties, and are not to be considered guarantees of any particular outcome.
•
All reproduction rights, quotations, broadcasting, publications reserved. No part of this presentation may be reproduced
or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any
information storage and retrieval system, without express written consent of IMS HEALTH.
•
© 2013 IMS Health Incorporated and its affiliates. All rights reserved. Trademarks are registered in the United States
and in various other countries.
The Next Frontier: Indonesia
2 © 2013 IMS Health Incorporated and its affiliates.

3. The pharmaceutical market is forecast to grow at a CAGR of 13.3%
(±3.0%) between 2011 and 2016, reaching US$7,825 million by
2016
Total Market Sales US$* (million)
Ex–Manufacturer Prices
Key Issues 2012-2016
9000
16%
8000
14%
12%
6000
10%
5000
8%
4000
6%
3000
4%
2000
2%
1000
0
0%
2011 2012 2013 2014 2015 2016
*Constant exchange rate (Qtr II 2012)
Source: IMS Health
The Next Frontier: Indonesia
3 © 2013 IMS Health Incorporated and its affiliates.
Annual Growth
US$ (million)
7000
− Gradual progress towards the implementation of a
single-payer national health insurance (NHI)
system by January 2014, combining the existing
health insurance schemes.
− Government efforts to upgrade the healthcare
infrastructure ahead of implementation of NHI,
with significant investments needed outside Java.
− Rapid expansion of the private hospital sector,
including development of hospital chains and
investment from foreign hospital groups.
− Overprescribing and polypharmacy will remain
common, although attempts may be made to
prevent misuse of antibiotics.
− Once NHI is in place, possibility of the introduction
of a national formulary and more attention to
rational prescribing.
− Growing pressure on prices following
implementation of NHI, with the possibility of the
creation of a national procurement agency.
− Expansion of field forces to boost geographic
coverage.

4. To get the full exclusive report
• Attend the IMS presentation at the
receive the full report. Register today at
The Next Frontier: Indonesia
4 © 2013 IMS Health Incorporated and its affiliates.
CPhI Southeast Asia Summit to
www.cphi - sea.com .

5. The Next Frontier: Indonesia
5 © 2013 IMS Health Incorporated and its affiliates.